Posted: 23 April 2024 Australia’s industry body for biotechnology, AusBiotech, has announced ex-Sanofi leader Rebekah Cassidy as its incoming Chief Executive Officer. Rebekah is an experienced leader with extensive strategy, policy, and media proficiency, coupled with deep health… The post AusBiotech announces incoming CEO first appeared on BioMelbourne Network ..read more

Posted: 19 April 2024 A new discussion paper from MTPConnect reveals how Australia is ready to play a leading role in the rise of the global radiopharmaceutical industry, as advanced therapies drive significant investment and rapid expansion. Radiopharmaceuticals… The post From Mines to Medicines – Australia Poised to Lead a Life-saving Revolution in Radiopharmaceuticals first appeared on BioMelbourne Network ..read more

Posted: 19 April 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has entered into an agreement with the Centre for Human… The post Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP76 first appeared on BioMelbourne Network ..read more

Posted: 19 April 2024 Hudson Institute’s reputation as a leader in inflammation research has been boosted by the appointment of two specialists in the field. Director and CEO Professor Elizabeth Hartland today announced that Professor Carl Walkley and Dr Sophia… The post New arrivals boost Hudson’s inflammation research leadership first appeared on BioMelbourne Network ..read more

Posted: 19 April 2024 A state-of-the-art service based at The Florey is increasing its capacity to protect the public from the fatal brain condition Creutzfeldt-Jakob disease (CJD). The rare neurodegenerative illness, caused by misfolded proteins called prions in… The post Increased monitoring capacity of deadly prion diseases first appeared on BioMelbourne Network ..read more

Posted: 19 April 2024 A suite of three electron microscopes, including one of the highest resolution microscopes in the world, now calls Monash home, helping scientists push the frontiers in materials science to solve complex worldwide challenges. The… The post Melbourne home to one-of-a-kind electron microscope first appeared on BioMelbourne Network ..read more

Posted: 19 April 2024 IDT Australia Limited (ASX: IDT) (IDT Australia) is pleased to announce that it has entered into a Master Service Agreement with Sanofi, an innovative global healthcare company, to support the preclinical formulation development and… The post IDT Secures contract with Sanofi Australia first appeared on BioMelbourne Network ..read more

Posted: 17 April 2024 In the lead up to the EOFY, BioMelbourne Network partner PRAXIS Australia are offering you and your team their most generous offer yet on their expert training solutions.  If you enrol now, you can receive 24%… The post Receive a discount on research and clinical trial training programs first appeared on BioMelbourne Network ..read more

Posted: 16 April 2024 Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation1 for the Company’s investigational glioma imaging product, TLX101-CDx (Pixclara™2, 18F-floretyrosine or 18F-FET). The granted Fast Track designation is for… The post TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation first appeared on BioMelbourne Network ..read more

Posted: 16 April 2024 Melbourne researchers have discovered a blood protein that could help detect which children will experience ongoing concussion symptoms more than two weeks after an injury. The research, led by Murdoch Children’s Research Institute (MCRI)… The post Protein could help detect delayed concussion recovery first appeared on BioMelbourne Network ..read more